ArticleBMC cancer2022

Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis.

Young Ju Suh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.